Skip to main content

Animations

MJFF Publications

7761 - 7770 of 8620 Results
Title
Year
  • Year
  • 2016
  • 2024
  • 2017
  • 2021
  • 2017
  • 2021
  • 2023
  • 2024
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.17111
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer’s Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2017.00580
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Urinary proteome profiling for stratifying patients with familial Parkinson’s disease
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202013257
    Citation Count: 128
  • Summary Details
    OPEN
    Title: In vivo detection of lateral–ventral tier nigral degeneration in Parkinson's disease
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23547
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson’s disease enrolled in PPMI
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00241-3
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16104
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: Parkinson's Disease Gene Screening in Familial Cases from Central and South America
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29931
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Parkinson's disease‐associated dyskinesia in countries with low access to levodopa‐sparing regimens
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27891
    Best OA location URL:
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives
    Journal Name: Brain Topography
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8
    Best OA location URL:
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.